Imiplex
Malvern
About Imiplex
Imiplex develops engineered protein nanostructures for applications in targeted therapeutics, biosensors, and functional biomaterials. Imiplex's technology capitalizes on the unique properties of proteins, including their ability to self-assemble with atomic precision, their structural and functional diversity, ease of engineering using recombinant DNA technology, and scalable production economics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (May 2012)
- Website: imiplex.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/imiplex-2829086 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.